The Corrupt Medical System’s Conflicts of Interest

Have you ever wondered why certain medications and treatments are chosen for cancer care? The answer lies in a flawed medical system where some doctors are influenced by money from big pharmaceutical companies. It’s well-known that the drug industry has problems, but many don’t realize that doctors play a big role in this issue. Academic doctors can make millions from these companies, while they are also the ones who create guidelines that promote these drugs. They end up prescribing these treatments to patients who are looking for unbiased advice but are really getting a slanted view. An examination of the National Comprehensive Cancer Network guidelines shows that over 85 percent of those who write them receive money from pharmaceutical companies.
Financial Relationships Between Doctors and Pharma
There have been numerous investigations and reports highlighting that pharmaceutical companies make substantial payments to doctors. These payments can be for various activities like consulting, speaking engagements, meals, and even research, but they can also subtly influence prescribing habits. ProPublica’s analysis, for instance, showed that doctors who receive payments related to specific drugs tend to prescribe those drugs more heavily than doctors without such financial ties. This suggests a correlation, if not direct causation, between pharmaceutical payments and prescription patterns.
RFK Jr. to unravel corporate capture of governmental health agencies
Reports say that guideline committee authors often have financial conflicts of interest. For example, a study indicated that a high percentage of guideline writers had relevant financial ties, with many receiving direct personal payments. This situation raises questions about the objectivity of medical guidelines, suggesting that financial incentives could potentially skew recommendations towards drugs that may not always be the most beneficial or cost-effective for patients. President-elect Donald Trump’s HHS pick, RFK Jr. told Dr. Phil how he’s going to unravel the corporate capture of governmental health agencies.
Conflicts of Interest Between Current FDA and CDC and Big Ag and Pharma
Corrupt medical System’s role in the chronic disease epidemic
The relationships between the Food and Drug Administration (FDA), the Centres for Disease Control and Prevention (CDC), and large agricultural and pharmaceutical companies raise significant concerns about conflicts of interest. These conflicts have led to situations where the priorities of these organizations may not align with the health and well-being of everyday people. The FDA and CDC, which are supposed to prioritize public health, sometimes seem to be too close to these big companies, leading to questions about whether they are more focused on profits than on protecting the population. Moreover, the United States is currently experiencing what they call a chronic disease epidemic that affects millions of people. Conditions like diabetes, heart disease, and obesity have reached alarming levels, leading experts to question the effectiveness of the current health system. The close ties between regulatory agencies and corporations contribute to this crisis, as the focus on profits may hinder the development of effective public health initiatives and solutions.
Understanding the Revolving Door: How It Affects Our Lives
The concept of the “revolving door” plays a big role in this situation, referring to the practice where individuals move between roles in government and industry. When officials shift from regulatory roles to positions within these powerful companies, it can create a system that benefits the few while potentially harming the many. This transition often results in policies that favour corporate interests, ultimately hurting the health of the public as these individuals prioritize their financial gain over the welfare of the country.
The Revolving Door: Why Public Health Suffers
One of the primary reasons for the decline in trust is the perception that healthcare has become profit-driven. Patients often feel that financial incentives influence medical decisions more than patient welfare, which has been exacerbated by high healthcare costs and perceived unnecessary procedures or tests recommended for profit, like we have seen in the increased popularity of Ozempic. The handling of public health issues, particularly during events like the COVID-19 pandemic, has led to a significant politicization of health advice and policies. This has resulted in a divide where trust in health institutions like the CDC has waned, especially among certain demographic groups or political affiliations.
Dr. Peter McCullough: The US Govt BRIBED Hospitals to Administer a Kidney and Liver Toxic Drug
Activist doctors said said that Remdesivir is so lethal it got nicknamed ‘Run Death Is Near’ after it started killing thousands of Covid patients in the hospital.  The experts claimed that Remdesivir would stop Covid; instead, it stopped kidney function, then blasted the liver and other organs. HHS added a 20% bonus on the entire hospital if they administered this liver and kidney-toxic drug.That 20% bonus could end up being a BIG pay day. Listen to Dr. Peter McCullough
Written By Tatenda Belle Panashe